If you registered for the 2022 Boston International Symposium in-person or virtually, you will have access to the entire virtual program until 30 December 2022.
After 30 December, the program sessions will be available on ISSCR.digital On-Demand.
Program
Keynote Speaker
Speakers & Topics
Preclinical Strategies
Sponsored by : Astellas Institute for Regenerative Medicine
April Craft, PhD, Boston Children’s Hospital, USA
Douglas A. Melton, PhD, Vertex Pharmaceuticals and Harvard University, USA
Su-Chun Zhang, MD, PhD, Duke-NUS Medical University, Singapore and University of Wisconsin-Madison, USA
Kareen Coulombe, PhD, Brown University, USA
Selecting Your Cell Line: Derivation and Characterization
Sponsored by: ElevateBio
Tenneille Ludwig, PhD, WiCell, USA
Nissim Benvenisty, PhD, Hebrew University, Israel
Jennifer Dashnau, PhD, Century Therapeutics, USA
What's In Your Product
Deborah Hursh, PhD, FDA Center for Biologics Evaluation and Research, USA
Bahram (Bob) Valamehr, PhD, MBA, FATE Therapeutics, USA
Angela Keightley, PhD, BlueRock Therapeutics, Canada
New Technologies/Where Are We Going?
Howard Kim, PhD, The New York Stem Cell Foundation (NYSCF), USA
Kapil Bharti, PhD, NIH, USA
Peter Zandstra, PhD, University of British Columbia, Canada
Kévin Alessandri, PhD, TreeFrog Therapeutics, France
Kiera Dwyer, Brown University, USA
Immunology for Cell Therapies
Ran Jing, PhD, Harvard Medical School, USA
Sonja Schrepfer, MD, PhD, Sana Biotechnology and University of California, San Francisco, USA
Shin Kaneko, MD, PhD, CiRA, Kyoto University, Japan
Balancing Science and Regulatory Requirements in Emerging Fields
Sponsored by: Cellino Biotech
Anthony Oro, MD, PhD, Stanford University, USA
Gesine Paul-Visse, MD, Lund University, Sweden
Melissa Carpenter, PhD, ElevateBio, USA
How to Accelerate with Accelerated Designations
Jane Lebkowski, PhD, Regenerative Patch Technologies, USA
Masayo Takahashi, MD, Vision Care, Inc., Japan
Jacqueline Barry, PhD, Cell & Gene Therapy Catapult, UK
Delivering Your Cell Product: Strategies for Success
Sponsored by: Vertex Pharmaceuticals
Timothy Kamp, MD, PhD, University of Wisconsin, USA
Cory R. Nicholas, PhD, Neurona Therapeutics, USA
This program is made possible with support from: